|
1
|
Cosman F, de Beur SJ, LeBoff MS, Lewiecki
EM, Tanner B, Randall S and Lindsay R: Clinician's guide to
prevention and treatment of osteoporosis. Osteoporos Int.
26:2045–23047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosen CJ, Ackert-Bicknell C, Rodriguez JP
and Pino AM: Marrow fat and the bone microenvironment:
Developmental, functional, and pathological implications. Crit Rev
Eukaryot Gene Expr. 19:109–124. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Justesen J, Stenderup K, Ebbesen EN,
Mosekilde L, Steiniche T and Kassem M: Adipocyte tissue volume in
bone marrow is increased with aging and in patients with
osteoporosis. Biogerontology. 2:165–171. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang R, Bai Y, Qin Z and Yu T: EgoNet:
Identification of human disease ego-network modules. BMC Genomics.
15:3142014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dutkowski J and Ideker T: Protein networks
as logic functions in development and cancer. PLOS Comput Biol.
7:e10021802011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Y, Shen X and Pan W: Network-based
support vector machine for classification of microarray samples.
BMC Bioinformatics. 10 (Suppl 1):S212009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khan AA, Betel D, Miller ML, Sander C,
Leslie CS and Marks DS: Transfection of small RNAs globally
perturbs gene regulation by endogenous microRNAs. Nat Biotechnol.
27:549–555. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lerebours F, Cizeron-Clairac G, Susini A,
Vacher S, Mouret-Fourme E, Belichard C, Brain E, Alberini JL,
Spyratos F, Lidereau R, et al: miRNA expression profiling of
inflammatory breast cancer identifies a 5-miRNA signature
predictive of breast tumor aggressiveness. Int J Cancer.
133:1614–1623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pignot G, Cizeron-Clairac G, Vacher S,
Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B,
Amsellem-Ouazana D, et al: microRNA expression profile in a large
series of bladder tumors: Identification of a 3-miRNA signature
associated with aggressiveness of muscle-invasive bladder cancer.
Int J Cancer. 132:2479–2491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng Y, Qu X, Li H, Huang S, Wang S, Xu Q,
Lin R, Han Q, Li J and Zhao RC: MicroRNA-100 regulates osteogenic
differentiation of human adipose-derived mesenchymal stem cells by
targeting BMPR2. FEBS Lett. 586:2375–2381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eskildsen T, Taipaleenmäki H, Stenvang J,
Abdallah BM, Ditzel N, Nossent AY, Bak M, Kauppinen S and Kassem M:
MicroRNA-138 regulates osteogenic differentiation of human stromal
(mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA.
108:6139–6144. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Goldenberg A, Wong KC and Zhang Z: A
probabilistic approach to explore human miRNA targetome by
integrating miRNA-overexpression data and sequence information.
Bioinformatics. 30:621–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aoki-Kinoshita KF and Kanehisa M: Gene
annotation and pathway mapping in KEGG. Methods Mol Biol.
396:71–91. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Venet D, Dumont JE and Detours V: Most
random gene expression signatures are significantly associated with
breast cancer outcome. PLOS Comput Biol. 7:e10022402011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gordon CA, Gong X, Ganesh D and Brooks JD:
NUSAP1 promotes invasion and metastasis of prostate cancer.
Oncotarget. 8:29935–29950. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liao W, Liu W, Yuan Q, Liu X, Ou Y, He S,
Yuan S, Qin L, Chen Q, Nong K, et al: Silencing of DLGAP5 by siRNA
significantly inhibits the proliferation and invasion of
hepatocellular carcinoma cells. PLoS One. 8:e807892013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu R, Guo CX and Zhou HH: Network-based
approach to identify prognostic biomarkers for estrogen
receptor-positive breast cancer treatment with tamoxifen. Cancer
Biol Ther. 16:317–324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gomez CR, Kosari F, Munz JM, Schreiber CA,
Knutson GJ, Ida CM, El Khattouti A, Karnes RJ, Cheville JC,
Vasmatzis G, et al: Prognostic value of discs large homolog 7
transcript levels in prostate cancer. PLoS One. 8:e828332013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xing XK, Wu HY, Chen HL and Feng HG: NDC80
promotes proliferation and metastasis of colon cancer cells. Genet
Mol Res. 15:gmr.150283122016. View Article : Google Scholar
|
|
22
|
Dougherty JD, Garcia AD, Nakano I,
Livingstone M, Norris B, Polakiewicz R, Wexler EM, Sofroniew MV,
Kornblum HI and Geschwind DH: PBK/TOPK, a proliferating neural
progenitor-specific mitogen-activated protein kinase kinase. J
Neurosci. 25:10773–10785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang YF, Pan YH, Cao Y, Fu J, Yang X,
Zhang MF and Tian QH: PDZ binding kinase, regulated by FoxM1,
enhances malignant phenotype via activation of β-Catenin signaling
in hepatocellular carcinoma. Oncotarget. 8:47195–47205.
2017.PubMed/NCBI
|
|
24
|
Shih MC, Chen JY, Wu YC, Jan YH, Yang BM,
Lu PJ, Cheng HC, Huang MS, Yang CJ, Hsiao M, et al: TOPK/PBK
promotes cell migration via modulation of the PI3K/PTEN/AKT pathway
and is associated with poor prognosis in lung cancer. Oncogene.
31:2389–2400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Louet JF, Coste A, Amazit L, Tannour-Louet
M, Wu RC, Tsai SY, Tsai MJ, Auwerx J and O'Malley BW: Oncogenic
steroid receptor coactivator-3 is a key regulator of the white
adipogenic program. Proc Natl Acad Sci USA. 103:17868–17873. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma X, Xu L, Wang S, Cui B, Li X, Xu J and
Ning G: Deletion of steroid receptor coactivator-3 gene ameliorates
hepatic steatosis. J Hepatol. 55:445–452. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Coste A, Louet JF, Lagouge M, Lerin C,
Antal MC, Meziane H, Schoonjans K, Puigserver P, O'Malley BW and
Auwerx J: The genetic ablation of SRC-3 protects against obesity
and improves insulin sensitivity by reducing the acetylation of
PGC-1{alpha}. Proc Natl Acad Sci USA. 105:17187–17192. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hartig SM, He B, Long W, Buehrer BM and
Mancini MA: Homeostatic levels of SRC-2 and SRC-3 promote early
human adipogenesis. J Cell Biol. 192:55–67. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ivanovska I, Ball AS, Diaz RL, Magnus JF,
Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson
AL, et al: MicroRNAs in the miR-106b family regulate p21/CDKN1A and
promote cell cycle progression. Mol Cell Biol. 28:2167–2174. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe
TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al:
Genomic profiling of microRNA and messenger RNA reveals deregulated
microRNA expression in prostate cancer. Cancer Res. 68:6162–6170.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu S, Huang S, Ding J, Zhao Y, Liang L,
Liu T, Zhan R and He X: Multiple microRNAs modulate p21Cip1/Waf1
expression by directly targeting its 3′ untranslated region.
Oncogene. 29:2302–2308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dutto I, Tillhon M, Cazzalini O, Stivala
LA and Prosperi E: Biology of the cell cycle inhibitor p21(CDKN1A):
Molecular mechanisms and relevance in chemical toxicology. Arch
Toxicol. 89:155–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
